Public Health


Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. The Public Health chapter examines how public health is governed and delivered in the United States. It includes explanations of key public health frameworks, services, capabilities and characteristics, how the public health system works in state, local and territorial governments, and public health funding, workforce, and communication challenges in an era of declining trust.

View the Chapter →


Filter

11 - 20 of 273 Results

  • Vaccine Coverage, Pricing, and Reimbursement in the U.S.

    Issue Brief

    The brief provides an overview of how vaccines are reimbursed and covered across government programs and different types of health insurance in the United States. It coverage regulations specific to COVID-19 vaccine(s).

  • Analysis: There is Significant Variation in State and Local Eligibility Criteria for Monkeypox Vaccines, and Vaccine Information is not Always Accessible

    News Release

    According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk.

  • Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States

    Issue Brief

    This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.

  • How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?

    Issue Brief

    Between 8 and 24 million people across the U.S. could be disenrolled from Medicaid during the unwinding of the program’s continuous enrollment provision. KFF's new analysis offers three illustrative scenarios for how state-level Medicaid enrollment could decline between March 2023 and May 2024, ranging from 8 percent to 28 percent of total enrollees. 

  • Ebola: Five Key Questions

    Other Post

    Ebola virus has a unique set of characteristics that determine how and why its spreads, and how deadly it can be. To better understand Ebola, this infographic compares it to twelve other infectious diseases that continue to represent public health challenges today and asks and answers five key questions about the disease.

  • Data Note: Update On Public Confidence In U.S. Health Institutions To Deal With Ebola

    Feature

    The October Kaiser Health Tracking Poll found that majorities of the public said that if a case of Ebola were diagnosed in their area, they would have a “great deal” or a “fair amount” of confidence in state, local, and federal health authorities to contain the disease and prevent it from spreading. Given the evolving news story, we re-surveyed the public from October 17-19 to determine whether confidence in health authorities to prevent the spread of Ebola has changed in light of more recent developments.

  • Kaiser Health Policy News Index October 2014: Ebola In U.S. And Africa Top Public Attention To Health News

    Kaiser Health Policy News Index: Special Focus On Ebola

    Feature

    With the Ebola outbreak in West Africa and individual cases in the U.S. and Europe making international headlines, the latest Kaiser Health Policy News Index examines Americans’ attention to the Ebola crisis, awareness of key facts about the disease, and views of the U.S. role in addressing Ebola in Africa and at home.